Liu and Knochel
was stirred overnight. The solvent was mostly evaporated and the
remaining aqueous suspension was extracted with CHCl3 and the
combined organic layers were washed with brine, dried (Na2SO4),
and evaporated to afford the crude product. Recrystallization
(EtOAc) gave 9 (101 mg, 95%) as bright yellow crystals. Mp
102.5-103.5 °C; 1H NMR (CDCl3, 400 MHz) δ 9.39 (s, 1H), 8.54
(d, J ) 5.3, 1H), 7.63 (d, J ) 5.3 Hz, 1H), 7.56 (s, 1H), 2.75 (s,
3H), 2.53 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ 149.4, 142.8,
134.6, 134.5, 133.0, 132.0, 128.2, 123.2, 117.2, 18.0, 17.6; IR (KBr)
3050 (w), 2945 (w), 2920 (w), 2855 (w), 1588 (m), 1564 (m), 1491
(m), 1433 (m), 1378 (m), 1274 (m), 1212 (w), 1072 (w) cm-1; MS
(EI, 70 eV) 235 (M+, 100), 220 (3), 156 (86), 141 (11), 128 (23),
116 (6), 102 (6), 77 (11); HRMS (EI) calcd for C11H10BrN
234.9997, found 235.0007.
Triazene (8a) was prepared from 1-(2-iodophenylazo)pyrrolidine
(1a) (903 mg, 3 mmol) and 7-bromo-5,8-dimethylisoquinoline (9)
(705 mg, 3 mmol) according to the procedures for the preparation
of 1n and yielding the pure product 8a (743 mg, 75%) as a pale
yellow solid. Mp 121.3-123.6 °C; 1H NMR (CDCl3, 600 MHz) δ
9.53 (s, 1H), 8.57 (d, J ) 5.7 Hz, 1H), 7.49 (d, J ) 7.6 Hz, 1H),
7.44 (s, 1H), 7.32-7.37 (m, 1H), 7.17-7.23 (m, 2H), 2.80-4.10
(br s, 4H), 2.62 (s, 3H), 2.49 (s, 3H), 1.83 (br s, 4H); 13C NMR
(CDCl3, 150 MHz) δ 150.1, 148.9, 142.0, 138.8, 135.9, 134.7,
134.2, 130.8, 130.7, 129.7, 128.3, 127.9, 124.9, 117.3, 117.0, 23.6,
18.3, 15.5; IR (KBr) 2990 (w), 2868 (w), 1597 (w), 1406 (s), 1315
(m), 1268 (m), 1200 (w), 1095 (w) cm-1; MS (EI, 70 eV) 330
(M+, 6), 260 (6), 245 (46), 232 (98), 217 (100), 202 (11), 189 (15),
108 (9); HRMS (EI) calcd for C21H22N4 330.1844, found 330.1844.
Aryl azide (7a) was prepared from the corresponding triazene
(8a) (165 mg, 0.5 mmol) according to the general procedure B and
yielding the pure product 7a (107 mg, 78%) as a yellow liquid. 1H
NMR (CDCl3, 300 MHz) δ 9.55 (s, 1H), 8.61 (d, J ) 5.7 Hz, 1H),
7.79 (d, J ) 5.7 Hz, 1H), 7.42-7.51 (m, 1H), 7.21-7.35 (m, 4H),
2.67 (s, 3H), 2.55 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ 150.0,
142.7, 138.1, 136.0, 135.2, 133.1, 132.8, 131.4, 131.0, 130.9, 129.0,
127.7, 124.7, 118.4, 117.3, 18.3, 15.1; IR (neat) 2923 (w), 2120
(s), 1599 (w), 1570 (w), 1487 (w), 1443 (w), 1386 (w), 1284 (m),
1095 (w), 961 (w) cm-1; MS (EI, 70 eV) 274 (M+, 10), 246 (100),
231 (80), 203 (10), 152 (5), 109 (6), 88 (4); HRMS (EI) calcd for
C17H14N4 274.1218, found 274.1232.
H); 13C NMR (CDCl3, 150 MHz) δ 157.3, 150.3, 143.1, 142.4,
138.8, 137.2, 135.0, 134.1, 131.1, 130.0, 128.1, 118.2, 117.5, 115.5,
114.4, 55.8, 23.9, 18.5, 15.8; IR (KBr) 2962 (w), 2850 (w), 1596
(m), 1495 (m), 1407 (m), 1319 (m), 1269 (m), 1209 (m), 1109
(w), 1035 (m), 817 (m) cm-1; MS (EI, 70 eV) 360 (M+, 28), 290
(22), 275 (15), 262 (100), 247 (56), 231 (22), 219 (18), 204 (15);
HRMS (EI) calcd for C22H24N4O 360.1950, found 360.1933.
Aryl azide (7b) was prepared from the corresponding triazene
(8b) (281 mg, 0.78 mmol) according to the general procedure C,
yielding the pure product 7b (223 mg, 94%) as a brown liquid. 1H
NMR (CDCl3, 300 MHz) δ 9.53 (s, 1H), 8.60 (d, J ) 5.8 Hz, 1H),
7.76 (d, J ) 5.8 Hz, 1H), 7.30 (s, 1H), 7.18 (d, J ) 8.8 Hz, 1H),
6.98 (dd, J ) 8.8, 3.1 Hz, 1H), 6.76 (d, J ) 3.1 Hz, 1H), 3.81 (s,
3H), 2.64 (s, 3H), 2.53 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ
156.6, 150.2, 150.1, 143.0, 135.9, 134.3, 133.4, 132.5, 131.0, 130.6,
127.7, 119.5, 117.2, 116.7, 114.6, 55.6, 18.4, 15.1; IR (neat) 2938
(w), 2110 (s), 1596 (m), 1488 (m), 1462 (m), 1420 (m), 1384 (m),
1285 (m), 1225 (m), 1177 (m), 1032 (m) cm-1; MS (EI, 70 eV)
304 (M+, 6), 276 (100), 261 (96), 246 (23), 233 (30), 218 (28),
204 (7), 117 (5), 102 (3); HRMS (EI) calcd for C18H16N4O
304.1324, found 304.1340.
9-Methoxyellipticine (3b). A solution of the aryl azide 7b (100
mg, 0.33 mmol) in mesitylene (3.3 mL) was heated at reflux. After
5 h, the solvent was evaporated in vacuo to give the crude product.
Purification by flash chromatography (methanol:ether ) 1:9) yielded
the pure product 3b (62 mg, 68%) as an amber solid. Mp 276.3-
1
278.5 °C dec (lit.37 mp 275-278 °C dec); H NMR (CDCl3, 300
MHz) δ 9.14 (s, 1H), 8.69 (d, J ) 5.2 Hz, 1H), 7.59 (d, J ) 8.4
Hz, 1H), 7.19 (d, J ) 5.2 Hz, 1H), 6.98 (d, J ) 2.6 Hz, 1H), 6.87
(dd, J ) 8.4, 2.6 Hz, 1H), 6.49 (s, 1H), 3.85 (s, 3H), 2.07 (s, 3H);
13C NMR (CDCl3, 75 MHz) δ 158.6, 152.4, 148.2, 146.1, 144.1,
143.4, 135.0, 124.2, 122.2, 118.5, 116.5, 115.5, 114.6, 112.7, 108.6,
55.7, 27.6, 18.9; IR (KBr) 3310 (s), 2921 (m), 1722 (w), 1588 (s),
1468 (s), 1367 (w), 1348 (w), 1285 (s), 1207 (m), 1027 (s) cm-1
;
MS (EI, 70 eV) 276 (M+, 100), 261 (60), 246 (27), 233 (27), 218
(33), 204 (5), 190 (10), 177 (5), 164 (7), 138 (7), 116 (7), 109 (7),
95 (5), 88 (5); HRMS (EI) calcd for C18H16N2O 276.1263, found
276.1268.
Triazene (20a) was prepared from 1-(2-iodophenylazo)pyrroli-
dine (1a) (160 mg, 0.53 mmol) and 6-bromo-5,8-dimethylisoquino-
line (19) (150 mg, 0.53 mmol) according to the procedure for the
preparation of 1n, yielding the pure product 20a (136 mg, 78%) as
a pale yellow solid. Mp 55.5-56.5 °C; 1H NMR (CDCl3, 300 MHz)
δ 9.42 (s, 1H), 8.56 (d, J ) 6.2 Hz, 1H), 7.80 (d, J ) 6.2 Hz, 1H),
7.49 (d, J ) 8.0 Hz, 1H), 7.31-7.38 (m, 1H), 7.30 (s, 1H), 7.18-
7.22 (m, 2H), 3.00-4.00 (br s, 4H), 2.73 (s, 3H), 2.36 (s, 3H),
1.77-1.87 (m, 4H); 13C NMR (CDCl3, 75 MHz) δ 149.6, 148.7,
142.9, 141.8, 136.1, 135.7, 131.3, 130.4, 129.1, 128.3, 126.9, 124.9,
117.6, 117.1, 65.8, 23.7, 18.2, 15.6; IR (KBr) 2970 (w), 2867 (w),
1612 (w), 1443 (w), 1408 (m), 1314 (m), 1268 (w), 1209 (w), 1157
(w), 1102 (w) cm-1; MS (EI, 70 eV) 330 (M+, 5), 260 (5), 245
(40), 232 (100), 217 (66), 202 (11), 189 (16), 108 (9); HRMS (EI)
calcd for C21H22N4 330.1844, found 330.1837.
Aryl azide (21a) was prepared from the corresponding triazene
(20a) (122 mg, 0.37 mmol) according to the general procedure C,
yielding the pure product 21a (96 mg, 95%) as a pale yellow liquid.
1H NMR (CDCl3, 300 MHz) δ 9.46 (s, 1H), 8.60 (d, J ) 5.8 Hz,
1H), 7.83 (d, J ) 5.8 Hz, 1H), 7.40-7.50 (m, 1H), 7.15-7.30 (m,
4H), 2.77 (s, 3H), 2.39 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ
149.7, 143.4, 138.9, 138.0, 135.7, 133.3, 132.6, 131.2, 130.1, 129.5,
129.1, 124.8, 118.4, 117.9, 117.7, 18.3, 15.3; IR (neat) 3057 (w),
2961 (w), 2923 (w), 2855 (w), 2123 (s), 2098 (s), 1612 (m), 1482
(m), 1382 (w), 1301 (m), 1277 (m), 1034 (w) cm-1; MS (EI, 70
eV) 274 (M+, 8), 246 (100), 231 (74), 217 (10), 204 (12), 189 (8),
176 (8), 152 (6), 122 (8), 108 (14); HRMS (EI) calcd for C17H14N4
274.1218, found 274.1221.
Ellipticine (3a). A solution of the aryl azide 7a (101 mg, 0.37
mmol) in mesitylene (5 mL) was heated at reflux. After 6 h, the
solvent was evaporated in vacuo to give the crude product.
Purification by flash chromatography (methanol:ether ) 1:9) yielded
the pure product 3a (52 mg, 57%) as a yellow solid. Mp 247.3-
1
249.1 °C (lit.36 mp 243-250 °C); H NMR (CDCl3, 600 MHz) δ
9.71 (s, 1H), 8.49 (d, J ) 5.8 Hz, 1H), 8.37 (d, J ) 7.8 Hz, 1H),
7.85 (d, J ) 5.8 Hz, 1H), 7.46-7.54 (m, 2H), 7.28-7.34 (m, 2H),
3.30 (s, 3H), 2.77 (s, 3H); 13C NMR (CDCl3, 150 MHz) δ 150.2,
144.6, 141.8, 141.2, 130.3, 129.5, 129.0, 127.4, 126.1, 124.3, 124.2,
120.2, 116.1, 115.1, 110.6, 14.9, 12.2; IR (KBr) 3480 (s), 1630
(m), 1605 (m), 1440 (w), 1400 (w), 1377 (w), 1303 (m), 1230 (m),
1010 (m) cm-1; MS (EI, 70 eV) 246 (M+, 100), 231 (97), 216 (6),
204 (12), 176 (6), 122 (6), 109 (5), 96 (6), 51 (3); HRMS (EI)
calcd for C17H14N2 246.1157, found 246.1145.
Triazene (8b) was prepared from 1-(4-methoxy-2-iodopheny-
lazo)pyrrolidine (6n) (993 mg, 3.0 mmol) and 7-bromo-5,8-
dimethylisoquinoline (9) (705 mg, 3 mmol) according to the
procedures for the preparation of 1n, yielding the pure product 8b
1
(680 mg, 63%) as a brown solid. Mp 62.1-64.5 °C; H NMR
(CDCl3, 600 MHz) δ 9.52 (s, 1H), 8.57 (d, J ) 6.0 Hz, 1H), 7.76
(d, J ) 6.0 Hz, 1H), 7.45 (d, J ) 9.0 Hz, 1H), 7.43 (s, 1H), 6.91
(dd, J ) 9.0, 2.8 Hz, 1H), 6.76 (d, J ) 2.8 Hz, 1H), 3.82 (s, 3H),
2.90-3.75 (br s, 4H), 2.62 (s, 3H), 2.51 (s, 3H), 1.77-1.84 (m, 4
(33) Harris, N. V.; Smith, C.; Bowden, K. Synlett 1990, 577.
(34) Kondo, Y.; Kojima, S.; Sakamoto, T. J. Org. Chem. 1997, 62, 6507.
(35) Lizos, D.; Tripoli, R.; Murphy, J. A. Chem. Commum. 2001, 2732.
(36) Sha, C. K.; Yang, J. F. Tetrahedron 1992, 48, 10645.
(37) Gribble, G. W.; Saulnier, M. G.; Obaza-Nutaitis, J. A.; Ketcha, D.
M. J. Org. Chem. 1992, 57, 5891.
7114 J. Org. Chem., Vol. 72, No. 19, 2007